VOCALE LBD+ for Caregivers of Persons With Lewy Body Dementia
Launched by UNIVERSITY OF WASHINGTON · Nov 16, 2022
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informal and/or lay caregiver of a patient with LBD
- • Can read, write, and speak English
- • Has access to a device that can be used for videoconferencing and/or phone calls
- • 18 years or older
- Exclusion Criteria:
- • Not an informal and/or lay caregiver
- • Cannot read and write in English
- • No access to a device that can be used for videoconferencing and/or phone calls Younger than 18 years old
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Oleg Zaslavsky, PhD
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials